Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase 2/3 Trial of Hydroxychloroquine In Covid-19 Kinetics

NCT04353271 is registered in ClinicalTrials.gov with University of South Alabama as lead sponsor.

NCT NCT04353271
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04353271 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase 2/3 Trial of Hydroxychloroquine In Covid-19 Kinetics
Lead sponsor
University of South Alabama
Phase
Phase 2/3
Overall status
Terminated
Start date
April 17, 2020
Completion date
July 8, 2020
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection, covid 19